A Randomized, Double Blind, Placebo Controlled Trial With Montelukast to Treat Bronchiolitis Obliterans Syndrome After Lung Transplantation
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Montelukast (Primary)
- Indications Bronchiolitis obliterans
- Focus Therapeutic Use
- 05 Mar 2015 Biomarkers information updated
- 15 Oct 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 07 Oct 2010 New trial record